ORCL
65
-2
AAP
24
6
ADSK
70
2
PM
62
-2
LMT
34
2
YUM
47
3
NDAQ
62
2
WM
79
3
PBI
69
4
EL
25
4
NKE
36
6
IR
66
3
ES
34
3
ROP
62
3
COF
60
2
WBA
48
4
JPM
69
2
PPL
54
-5
ORLY
62
2
VTR
47
-7
ORCL
65
-2
AAP
24
6
ADSK
70
2
PM
62
-2
LMT
34
2
YUM
47
3
NDAQ
62
2
WM
79
3
PBI
69
4
EL
25
4
NKE
36
6
IR
66
3
ES
34
3
ROP
62
3
COF
60
2
WBA
48
4
JPM
69
2
PPL
54
-5
ORLY
62
2
VTR
47
-7
Financhill
Back

Vera Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63

VERA
Vera Therapeutics

Last Price:
48.30
Seasonality Move:
52.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Vera Therapeutics Price Quote

$48.30
-0.01 (2.7%)
(Updated: November 23, 2024 at 5:59 AM ET)

Vera Therapeutics Key Stats

Buy
63
Vera Therapeutics (VERA) is a Buy
Day range:
$47.10 - $48.94
52-week range:
$12.28 - $51.61
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
10.58%
Volume:
793K
Avg. volume:
950K
1-year change:
267.1%
Market cap:
$3.1B
Revenue:
$0
EPS:
$-2.61

How Much Does Vera Therapeutics Make?

Data Unavailable

Is Vera Therapeutics Growing As A Company?

Data Unavailable

Vera Therapeutics Stock Price Performance

What Is Vera Therapeutics 52-Week High & Low?

Vera Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vera Therapeutics?

  • How Much Debt Does Vera Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vera Therapeutics Have?
    Cash and short term investments quarterly total is $353.3M
  • What Is Vera Therapeutics’s Book Value Per Share?
    Book value per share is 5.25

Is Vera Therapeutics Cash Flow Positive?

  • What Is VERA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$120.6M
  • What Is Vera Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $305.5M
  • What Is Vera Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$185.1M

Vera Therapeutics Return On Invested Capital

Data Unavailable

Vera Therapeutics Earnings Date & Stock Price

Vera Therapeutics Competitors

  • Who Are Vera Therapeutics's Competitors?
    Below is a list of companies who compete with Vera Therapeutics or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • PROCEPT BioRobotics Corp (PRCT)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Vera Therapeutics Dividend Yield

Vera Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -38.73%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 64.58
Upside from Last Price: 33.69%

Major Shareholders

  • How many VERA shares are owned by institutional investors?
    79.8M VERA shares are owned by institutional investors
  • How many VERA shares are owned by insiders?
    615.9K VERA shares are owned by insiders